Home › Genetic Disorders › New York › New York City
Genetic Disorders clinical trials in New York City, NY
5 studies for Genetic Disorders are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
RecruitingObservational study
- Icahn School of Medicine at Mount Sinai, New York
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
RecruitingPhase 3
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
RecruitingPhase 1/2
- Icahn School of Medicine at Mount Sinai, New York
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
RecruitingPhase 1/2
- Icahn School of Medicine at Mount Sinai - Clinical Research Unit, New York
STXBP1 and SYNGAP1 Related Disorders Natural History Study
RecruitingObservational study
- Weill Cornell Medicine, New York
About Genetic Disorders
A mutation in a person's genes can cause a medical condition called a genetic disorder. Learn about the types and how they are detected.
More about Genetic Disorders on MedlinePlus
Genetic Disorders trials in other cities
- Washington, DC12 studies
- Philadelphia, PA9 studies
- Houston, TX8 studies
- Durham, NC7 studies
- Los Angeles, CA6 studies
- Mountain View, CA6 studies
- Boston, MA6 studies
- Miami, FL5 studies
- San Diego, CA5 studies
- Dallas, TX4 studies
- Chicago, IL4 studies
- Aurora, CO4 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.